Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states.

Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states.
复制标题

DOI:
10.1016/j.pain.2010.12.014
复制
发表时间:
2011-03
期刊:
影响因子:
7.4
通讯作者:
Luo DZ
Luo DZ
中科院分区:
医学1区
文献类型:
--
作者:
Boroujerdi A;Zeng J;Sharp K;Kim D;Steward O;Luo DZ

文献摘要

参考文献

被引文献

相似文献

Spinal cord injury (SCI) commonly results in the development of neuropathic pain, which can dramatically impair the quality of life for SCI patients. SCI induced neuropathic pain can be manifested as both tactile allodynia (a painful sensation to a non-noxious stimulus) and or hyperalgesia (an enhanced sensation to a painful stimulus). The mechanisms underlying these pain states are poorly understood. Clinical studies have shown that gabapentin, a drug that binds to the voltage gated calcium channel alpha-2-delta-1 subunit (Cavα2δ-1) proteins is effective in the management of SCI induced neuropathic pain. Accordingly, we hypothesized that tactile allodynia post SCI is mediated by an upregulation of Cavα2δ-1 in dorsal spinal cord (DSC). To test this hypothesis, we examined if SCI-induced dysregulation of spinal Cavα2δ-1 plays a contributory role in below-level allodynia development in a rat spinal T9 contusion injury model. We found that Cavα2δ-1 expression levels were significantly increased in L4-6 dorsal, but not ventral, spinal cord of SCI rats that correlated with tactile allodynia development in the hindpaw plantar surface. Furthermore, both intrathecal gabapentin treatment and blocking SCI induced Cavα2δ-1 protein upregulation by intrathecal Cavα2δ-1 antisense oligodeoxynucleotides could reverse tactile allodynia in SCI rats. These findings support that SCI induced Cavα2δ-1 upregulation in spinal dorsal horn is a key component in mediating below-level neuropathic pain development and selectively targeting this pathway may provide effective pain relief for SCI patients.
DOI: 10.1016/j.neuroscience.2009.03.055
发表时间: 2009-07-07
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Gwak, Y. S.;Hulsebosch, C. E.
通讯作者: Hulsebosch, C. E.
DOI: 10.1097/00007632-200302150-00005
发表时间: 2003-02-15
期刊: SPINE
影响因子: 3
作者:
Ahn, SH;Park, HW;Bae, JH
通讯作者: Bae, JH
DOI: 10.1097/01.brs.0000112068.16108.3a
发表时间: 2004-04-01
期刊: SPINE
影响因子: 3
作者:
Levendoglu, F;Ögün, CÖ;Ugurlu, H
通讯作者: Ugurlu, H
DOI: 10.1074/jbc.271.10.5768
发表时间: 1996-03-08
影响因子: 4.8
作者:
Gee, NS;Brown, JP;Woodruff, GN
通讯作者: Woodruff, GN
DOI: 10.1089/neu.1997.14.517
发表时间: 1997-08-01
影响因子: 4.2
作者:
Christensen, MD;Hulsebosch, CE
通讯作者: Hulsebosch, CE